BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/5/2021 1:41:02 PM | Browse: 551 | Download: 1392
 |
Received |
|
2020-12-12 11:51 |
|
Peer-Review Started |
|
2020-12-12 11:53 |
|
First Decision by Editorial Office Director |
|
2020-12-17 19:56 |
|
Return for Revision |
|
2020-12-17 19:56 |
|
Revised |
|
2020-12-30 14:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-01-12 12:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-01-12 18:12 |
|
Articles in Press |
|
2021-01-12 18:12 |
|
Edit the Manuscript by Language Editor |
|
2021-01-24 08:31 |
|
Typeset the Manuscript |
|
2021-02-03 02:24 |
|
Publish the Manuscript Online |
|
2021-02-05 10:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Li-Qi Sun, Li-Si Peng, Jie-Fang Guo, Fei Jiang, Fang Cui, Hao-Jie Huang and Zhen-Dong Jin |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shanghai Association for Science and Technology |
19411951602 |
| National Natural Science Foundation of China |
81770642 |
|
| Corresponding Author |
Zhen-Dong Jin, MD, PhD, Director, Director, Professor, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Changhai Road No. 168 Yangpu District, Shanghai 200433, China. zhendongjin@163.com |
| Key Words |
Serum tumor markers; Diagnosis; Advanced cystic mucinous neoplasms; Mucinous cystic neoplasms; Intraductal papillary mucinous neoplasms |
| Core Tip |
The value of serum tumor markers (STMs) in predicting advanced cystic mucinous neoplasms (A-cMNs) has not been well studied except for carbohydrate antigen (CA) 19-9. Our study illustrates for the first time the potential value of multiple STMs in the diagnosis of A-cMNs. CA19-9 was the most accurate STM in predicting A-cMNs with a moderate ability. CEA, CA125 and CA724 showed a low ability to predict A-cMNs. CA125 may be specific to the diagnosis of advanced mucinous cystic neoplasms. CA242 was not identified as useful in predicting A-cMNs in our study. The combination of STMs could improve sensitivity in predicting A-cMNs. |
| Publish Date |
2021-02-05 10:20 |
| Citation |
Sun LQ, Peng LS, Guo JF, Jiang F, Cui F, Huang HJ, Jin ZD. Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas. World J Gastroenterol 2021; 27(6): 501-512 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i6/501.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i6.501 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
